Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID 19 hospitalized meta-analysis

Huang, 2020
 
ChiCTR2000029542
RCTchloroquinelopinavir/ritonavirCOVID 19 hospitalizedsome concern
10/12 inconclusive
    Huang, 2020 OBSchloroquinecontrolCOVID 19 hospitalizedcritical
    197/176 suggested
    • suggested 5.1-fold increase in PCR-negative conversion (14-day) but with a very low degree of certainty due to critical risk of bias

    COVID-19 mild to moderate meta-analysis

    NCT04342650, 2020
     
    NCT04342650
    RCTchloroquineplaceboCOVID-19 mild to moderateNA
    -/- inconclusive

      PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
      Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).